US 7592368
Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
granted A61PA61P31/12A61P31/18
Quick answer
US patent 7592368 (Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P31/12, A61P31/18, A61P43/00